Meng Sun is a highly motivated professional specializing in mRNA process development and production. They currently serve as a Senior Advisor at Eli Lilly and Company and have held previous roles as a Senior Scientist at Life Edit Therapeutics and an Associate Scientist at Nitto Denko Avecia Inc. Meng completed a Ph.D. in Biochemistry from The Ohio State University and has extensive research experience, particularly in biomolecule synthesis and purification. Their analytical skills are complemented by proficiency in various laboratory technologies and programming languages, making them a strong asset in fast-paced research environments.
This person is not in the org chart
This person is not in any teams
This person is not in any offices